Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertension Patients

NCT00615108 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00615108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00615108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertension Patients
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
December 31, 2006
Completion date
Not reported
Enrollment
3,148 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension